Cargando…

Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis

BACKGROUND: Hypophysitis is a well-recognized immune-related adverse event in patients treated with immune checkpoint inhibitors for cancer. Some anterior pituitary hormones may recover; however, secondary adrenal insufficiency is usually permanent. CASE PRESENTATION: A 26-year old male with metasta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thapi, Sahityasri, Leiter, Amanda, Galsky, Matthew, Gallagher, Emily J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739970/ https://www.ncbi.nlm.nih.gov/pubmed/31511065 http://dx.doi.org/10.1186/s40425-019-0729-3

Ejemplares similares

SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy
por: Thapi, Sahityasri, et al.
Publicado: (2019)

MON-370 Isolated Secondary Adrenal Insufficiency in the Absence of Hypophysitis Secondary to Immune Checkpoint Inhibitors
por: Lu, Mary, et al.
Publicado: (2019)

FRI238 A Rare Combination Of Thyroiditis And Secondary Adrenal Insufficiency Likely Secondary To Hypophysitis In A Patient Treated With Immune Checkpoint Inhibitors
por: Patel, Shivani, et al.
Publicado: (2023)

THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System
por: Gogerly-Moragoda, Mahalya, et al.
Publicado: (2023)

SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019)

MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors
por: Brooks, Danielle, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor Therapy Associated Hypophysitis
por: Mahzari, Moeber, et al.
Publicado: (2015)

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
por: Stagnetto, Margot, et al.
Publicado: (2020)

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns
por: Nguyen, Ha, et al.
Publicado: (2021)

Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency
por: Manaka, Katsunori, et al.
Publicado: (2021)

Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors
por: Helderman, N.C., et al.
Publicado: (2023)

Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma
por: Mishima, Yuka, et al.
Publicado: (2018)

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge
por: Park, Benjamin C, et al.
Publicado: (2022)

Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
por: Chen, Piaohong, et al.
Publicado: (2023)

PSAT042 Adrenal Insufficiency Associated to Immune Checkpoint Inhibitors
por: Barreto, Brigida Colon, et al.
Publicado: (2022)

LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022)

SAT-411 Vitamin D Levels and Risk of Thyroid Immune Related Adverse Events in Patients on Immune Checkpoint Inhibitors
por: Newman, Samantha Kass, et al.
Publicado: (2020)

SUN-626 Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus in a Seer-Medicare Cohort
por: Thapi, Sahityasri, et al.
Publicado: (2020)

FRI257 Adrenal Insufficiency Secundary Due Immune Checkpoint Inhibitors Therapy
por: Rivera, Sandra Rocio, et al.
Publicado: (2023)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function
por: Jessel, Shlomit, et al.
Publicado: (2022)

Is this really just “fatigue”? A case series of immune‐related central adrenal insufficiency secondary to immune checkpoint inhibitors
por: Nagasaka, Misako, et al.
Publicado: (2018)

Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
por: Baek, Jong Ha, et al.
Publicado: (2016)

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
por: Wei, Khor Zhong, et al.
Publicado: (2019)

SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020)

Early Detection of Immune-Mediated Hypophysitis With Use of Checkpoint Inhibitor Immunotherapy
por: Yossef, Kristena, et al.
Publicado: (2022)

Adrenal Insufficiency Masquerading as Primary Hypothyroidism Following Immune Checkpoint Inhibitors Treatment
por: Salim, Michael, et al.
Publicado: (2021)

Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study
por: Cui, Kai, et al.
Publicado: (2022)

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Fujita, Yasunori, et al.
Publicado: (2023)

Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
por: Cohan, Pejman
Publicado: (2016)

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature
por: Salinas, Carlos, et al.
Publicado: (2020)

Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome
por: Kanie, Keitaro, et al.
Publicado: (2021)

LBODP071 Early Detection Of Immune-mediated Hypophysitis With Use Of Checkpoint Inhibitor Immunotherapy
por: Lai, William, et al.
Publicado: (2022)

FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023)

Eosinophil counts can be a predictive marker of immune checkpoint inhibitor-induced secondary adrenal insufficiency: a retrospective cohort study
por: Takayasu, Shinobu, et al.
Publicado: (2022)

Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
por: Druce, Irena, et al.
Publicado: (2022)

Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor Therapy
por: Kim, Woorim, et al.
Publicado: (2023)

MON-181 Clinical Features of Immune Checkpoint Inhibitor-Related Adrenal Insufficiency: A Retrospective Analysis
por: Zhou, Qinwen Jenny, et al.
Publicado: (2020)

Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
por: Xiang, Jing, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Hypophysitis in Renal Cell Carcinoma: Two Contrasting Case Presentations
por: Okigbo, Chinelo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_khsqsvuel2dl8088rekh14up00